Skip to main content
Thalys Medical Technology Group Corporation. logo

Thalys Medical Technology Group Corporation. — Investor Relations & Filings

Ticker · 603716 ISIN · CNE1000030C3 Shanghai Stock Exchange Wholesale and retail trade
Open in API
Filings indexed 1,802 across all filing types
Latest filing 2026-06-02 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 603716

About Thalys Medical Technology Group Corporation.

https://www.thalys.net.cn/

Thalys Medical Technology Group Corporation specializes in providing integrated solutions for the medical diagnostics sector. The company primarily focuses on the distribution of in-vitro diagnostic (IVD) reagents and instruments, alongside the implementation of intensive procurement and supply chain management services, known as SPD (Supply, Processing, and Distribution). By leveraging information technology, Thalys optimizes hospital logistics and inventory management for medical consumables. Its service portfolio includes the provision of laboratory automation systems, technical support, and maintenance for diagnostic equipment. The group also operates independent clinical laboratories, offering comprehensive testing services to healthcare providers. Thalys collaborates with manufacturers to deliver a wide range of diagnostic products across various clinical disciplines, including immunology, biochemistry, and molecular diagnostics.

Recent filings

Filing Released Lang Actions
关于出售控股子公司股权的公告
Regulatory Filings Classification · 60% confidence The document is a formal regulatory announcement in Chinese regarding the sale of a 50% equity interest in a controlling subsidiary (“出售控股子公司股权的公告”). It lays out transaction terms, parties, board approval, financials, and completion conditions. It is not an annual or interim report containing full financial statements (exclude 10-K/IR), nor a proxy, dividend notice, ESG report, or director dealing. It is not an AGM presentation, call transcript, or financing update. It does not involve a share issue or stock split (SHA) nor a buyback of treasury shares (POS). It is not a takeover or merger bid (TAR/MA). It is a standalone transaction announcement that doesn’t fit the other specific categories – thus it falls under general regulatory filings (RNS).
2026-06-02 Chinese
关于完成工商变更登记并换发营业执照的公告
Share Issue/Capital Change Classification · 88% confidence The document is a corporate announcement by 塞力斯医疗科技集团股份有限公司 describing the completion of industrial and commercial registration changes, including the increase of registered capital and issuance of a new business license following the conversion of its convertible bonds (“塞力转债”). It details share capital changes (from 210,139,246 to 225,790,770 shares) and the updated registration information. This constitutes a capital change announcement. Therefore, it fits the “Share Issue/Capital Change” category (SHA).
2026-05-27 Chinese
国浩律师（上海）事务所关于塞力斯医疗科技集团股份有限公司2025年年度股东会之法律意见书
Regulatory Filings Classification · 85% confidence The document is a legal opinion letter (“法律意见书”) prepared by a law firm for the 2025 annual shareholders’ meeting. It provides legal confirmation on the convening, procedure, participant qualifications, and voting results, but is not the actual meeting minutes, presentation deck, vote-result announcement, or proxy statement. There is no dedicated “legal opinion letter” category, so this is best treated as a miscellaneous compliance/regulatory filing. Therefore, it falls under Regulatory Filings (RNS).
2026-05-19 Chinese
2025年年度股东会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 91% confidence The document is a formal announcement of the resolutions passed at the 2025 Annual General Meeting of shareholders, detailing meeting attendance and the voting results for each proposal. It does not present financial statements or serve as a full report but exclusively reports voting outcomes. Therefore, it matches the definition of a Declaration of Voting Results & Voting Rights Announcements (DVA).
2026-05-19 Chinese
2025年年度股东会会议资料（更新）
AGM Information Classification · 95% confidence The document is titled "2025年年度股东会会议资料" which translates to "2025 Annual General Meeting (AGM) Meeting Materials." It contains detailed information about the 2025 Annual General Meeting of shareholders, including meeting notices, agenda, proposals, voting procedures, board reports, and other materials typically shared with shareholders during an AGM. The content includes multiple agenda items such as the board's work report, profit distribution plan, auditor appointment, director remuneration, amendments to company bylaws, and shareholder return plans. The document is comprehensive and clearly intended as meeting materials for the AGM rather than a report publication announcement or a brief notice. It is not a transcript of a call, nor an earnings release or audit report. It is not a proxy solicitation or voting results announcement but the actual meeting materials. Therefore, the document fits the category of AGM Information (AGM-R). The document length (15,000 characters) and detailed content support this classification with high confidence.
2026-05-08 Chinese
关于集中竞价减持已回购股份计划的公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement regarding a plan to reduce (sell) shares that the company previously repurchased. It details the number of shares to be sold, the timing, the reasons, and compliance with regulatory guidelines. It is not a financial report, earnings release, or management discussion. It specifically concerns the company's plan to sell its own shares that were bought back, which fits the category of a Transaction in Own Shares (POS). The document length is 2690 characters, which is relatively short but contains substantive information about the share repurchase and reduction plan, not just a brief notice or report publication announcement. Therefore, the appropriate classification is POS with high confidence.
2026-05-08 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.